Catalyst overview
Research summary
This catalyst tracks a Phase 1 data readout for GS-6791 (NX-0479) in Rheumatoid arthritis, Atopic dermatitis. The expected timing is based on the latest available company guidance and may change.
07/09/26:- Gilead continues ongoing healthy volunteer Phase 1 study.
Verification
Confirm timing and program details against the company announcement or filing.